Citation:Hengge UR, Wallerand A, Stutzki A, Kockel N 2007

Citation

Hengge UR, Wallerand A, Stutzki A, Kockel N. Cost-effectiveness of reduced follow-up in malignant melanoma. J Dtsch Dermatol Ges 2007 Oct;5(10):898-907 Available from: http://www.ncbi.nlm.nih.gov/pubmed/17910672.

Critical appraisals

• Assign a critical appraisal

Cited by

1. Follow up after initial definitive treatment for each stage of melanoma
2. What investigations should be performed following a diagnosis of primary cutaneous melanoma for asymptomatic stage I and stage II patients?